Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) traded up 5.1% on Tuesday . The stock traded as high as $136.56 and last traded at $136.56. Approximately 25 shares were traded during trading, a decline of 96% from the average session volume of 617 shares. The stock had previously closed at $129.94.
Analyst Ratings Changes
Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, Pro Medicus has an average rating of “Hold” and an average price target of $155.00.
View Our Latest Stock Analysis on Pro Medicus
Pro Medicus Price Performance
About Pro Medicus
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Recommended Stories
- Five stocks we like better than Pro Medicus
- Home Depot Analysts See a Path to $375 and Beyond
- RTX Stock Gets a Radar Lock on a $23B Navy Win
- Berkshire Just Made a Huge Alphabet Bet—Should You Follow?
- Michael Burry Is Betting Against Palantir Again—Should Investors Care?
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
